Article metrics

Download PDFPDF
Concise report
Abatacept or tocilizumab after rituximab in rheumatoid arthritis? An exploratory study suggests non-response to rituximab is associated with persistently high IL-6 and better clinical response to IL-6 blocking therapy

 

Online download statistics by month:

Online download statistics by month: January 2014 to May 2021

AbstractFullPdf
Jan 2014791148259
Feb 20141304154
Mar 2014933140
Apr 2014120475192
May 201436556105
Jun 20142504561
Jul 20141493349
Aug 20141192234
Sep 2014952535
Oct 20141052730
Nov 2014671624
Dec 2014541827
Jan 2015531217
Feb 2015552417
Mar 2015502021
Apr 2015461715
May 2015531615
Jun 20151081211
Jul 2015521518
Aug 2015421014
Sep 201549915
Oct 2015561618
Nov 2015401210
Dec 201556814
Jan 201638108
Feb 2016431310
Mar 201651314
Apr 2016422616
May 2016211413
Jun 20163645
Jul 20164218
Aug 20163197
Sep 201632711
Oct 201641817
Nov 2016571517
Dec 201622811
Jan 201737128
Feb 20173449
Mar 20175196
Apr 20173051
May 20173784
Jun 2017461217
Jul 20176014
Aug 20175737
Sep 201711565
Oct 20176967
Nov 20178458
Dec 20175946
Jan 201812599
Feb 2018110114
Mar 201879128
Apr 201845114
May 20188844
Jun 20188545
Jul 20189378
Aug 2018116167
Sep 201873107
Oct 20185843
Nov 201870104
Dec 20185921
Jan 2019261275
Feb 20194633
Mar 201999116
Apr 20196195
May 20196434
Jun 20194442
Jul 20195476
Aug 20197886
Sep 20197689
Oct 20199776
Nov 20195696
Dec 20198454
Jan 20207522
Feb 202072103
Mar 20204153
Apr 20204410
May 20204423
Jun 20203756
Jul 20203564
Aug 20204720
Sep 20207434
Oct 20204976
Nov 20202030
Dec 20204453
Jan 20217640
Feb 20216761
Mar 20216356
Apr 20216232
May 202126106
Total811411811489